NeoGenomics Dividend
Dividend criteria checks 0/6
NeoGenomics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 1.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$0.66 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Investors Interested In NeoGenomics, Inc.'s (NASDAQ:NEO) Revenues
Mar 30
Investor Optimism Abounds NeoGenomics, Inc. (NASDAQ:NEO) But Growth Is Lacking
Dec 26Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Aug 23Risks To Shareholder Returns Are Elevated At These Prices For NeoGenomics, Inc. (NASDAQ:NEO)
Jul 16NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt
Apr 18We Think NeoGenomics (NASDAQ:NEO) Has A Fair Chunk Of Debt
Jan 10NeoGenomics: Market Punishment Continues, But Looks Justified
Sep 30NeoGenomics grants CEO restricted shares, stock options
Aug 17Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt
Aug 10NeoGenomics rises ~14% on strong Q2 result
Aug 09NeoGenomics gets new CEO
Jul 21NeoGenomics: Refrain From Portfolio Allocation, Negligible Upside Potential
Jun 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Apr 22Neogenomics: Poor Performance, CEO Departure Create Downward Share Price Spiral
Apr 08Why NeoGenomics, Inc. (NASDAQ:NEO) Could Be Worth Watching
Feb 11Is NeoGenomics (NASDAQ:NEO) Weighed On By Its Debt Load?
Jan 07NeoGenomics: Gambling On Growth
Dec 16NeoGenomics: Profitability Headwinds Compress Valuation, Shares
Sep 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Sep 24NeoGenomics: Strong Growth Potential For A Leader In Cancer Diagnostic Testing
Jul 02NeoGenomics completes Inivata acquisition
Jun 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if NEO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NEO's dividend payments have been increasing.
Dividend Yield vs Market
| NeoGenomics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NEO) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Healthcare) | 1.7% |
| Analyst forecast in 3 Years (NEO) | 0% |
Notable Dividend: Unable to evaluate NEO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NEO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate NEO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NEO has not reported any payouts.